2005December 20, 2005Maxygen Announces Management Changes December 15, 2005Roche and Maxygen to Co-Develop Recombinant Factor VIIa Therapeutics for Acute Bleeding December 14, 2005Maxygen to Host 2005 Year End Conference Call on December 15, 2005 December 14, 2005Maxygen Announces Achievement of Milestone in Roche Alliance December 9, 2005Maxygen Appoints Louis G. Lange to its Board of Directors October 31, 2005Maxygen to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference October 25, 2005Maxygen Reports Third Quarter 2005 Financial Results October 20, 2005Maxygen Announces $14.4 Million in U.S. Government Funding to Advance HIV Vaccine Research October 17, 2005Maxygen to Host Third Quarter 2005 Earnings Conference Call on October 25, 2005 July 26, 2005Maxygen Reports Second Quarter 2005 Financial Results June 16, 2005Maxygen Consolidates to Focus Resources on Product Development June 9, 2005Maxygen, Inc. Announces Webcast of Corporate Presentation at the Goldman Sachs 26th Annual Global Healthcare Conference April 26, 2005Maxygen Reports First Quarter 2005 Financial Results March 30, 2005Maxygen Announces Achievement of Milestone in Alliance with Roche March 8, 2005Maxygen, Inc. Announces Webcast of Corporate Presentation at the JP Morgan Small Cap Conference February 22, 2005Codexis to Acquire Julich Fine Chemicals, Leading European Biocatalyst and Pharmaceutical Intermediate Provider February 8, 2005Maxygen Reports Fourth Quarter and Year End 2004 Financial Results February 2, 2005Maxygen to Host Fourth Quarter and Year End 2004 Earnings Conference Call on February 8, 2005
Return to News
|
